Get a reply from this employer
Your resume and cover letter, tailored to exactly what they’re hiring for.
Zealand Pharma A/S is seeking a Senior Scientist DMPK to drive DMPK science from early discovery through development across small molecules, peptides and protein therapeutics. You will support discovery platforms, oversee studies, and turn data into clear insights to guide project decisions.
You will lead internal and CRO-driven studies, ensuring quality, timelines, and documentation, while delivering comprehensive ADME summaries and supporting governance milestones.
Does it excite you to work with drug metabolism and pharmacokinetics across peptides, proteins and small molecules, and do you have experience with in vitro ADME assays and liquid chromatography-mass spectrometry (LC-MS) bioanalysis? If this sounds like you, and you are ready to take on a broad area of responsibilities, then you could be our new colleague. Your new position As Senior Scientist DMPK, you will drive DMPK science from early discovery through development, across a range of modalities. You will support the DMPK discovery platforms and oversee studies run both in-house and with external partners. Your work will turn data into clear insights that guide project decisions and support governance milestones. The role stands out through its focus on peptide drugs for obesity and metabolic health, its mix of in-house and external study work, and the chance to shape digital and automation-enabled approaches within DMPK workflows.
We offer exciting responsibilities:
You will join the Global DMPK department within Pharmacokinetics, Immunogenicity and Bioanalytical Sciences, working closely with cross-functional R&D stakeholders (e.g., Discovery, Translational, Toxicology, Clinical Pharmacology, and Regulatory) to shape study strategies, interpret data, and communicate DMPK risks and recommendations.
We have a unique culture, characterized by excellent teamwork and strong engagement across the organization. And we want you to help us strengthen this culture. Making bonds is at the core of everything we do. From discovering and developing the best new peptide drugs for patients, to engaging with our partners or connecting with each other. We bond through curiosity and playfulness as a team, allowing ourselves to challenge common thinking and drive future innovation. Join us and let’s bond and be bold.
We are committed to an inclusive recruitment process and welcome applications from all job applicants.
Zealand Pharma A/S (Nasdaq: ZEAL) is a biotechnology company focused on advancing medicines for obesity and metabolic health. Combining more than 25 years of peptide R&D expertise with a proprietary data platform that leverages advanced data-driven and AI/ML approaches, Zealand Pharma aims to lead a new era in obesity and metabolic health. To date, more than ten Zealand Pharma-invented drug candidates have entered clinical development, of which two products have reached the market and three candidates are in late-stage development. The Company has collaborations with global pharmaceutical and biotechnology partners for research, development, and commercialization. Founded in 1998, Zealand Pharma is headquartered in Copenhagen, Denmark, with a U.S. presence in Boston, Massachusetts. Learn more at www.zealandpharma.com.
#LI-onsite
In obesity, our peptide capabilities place us in a unique position to address a vast global health challenge and positively impact hundreds of millions of lives.
Within rare diseases, we have a long-standing commitment to deliver new treatments to patients living with congenital hyperinsulinism and short bowel syndrome.
For chronic inflammatory diseases, we are progressing peptide programs focused on high-profile targets shown to be difficult to address with small molecules and antibodies.
For type1 diabetes, we aspire to change the management of this disease.
Our strategy is to pursue global co-development and commercialization partnerships that complement and extend our capabilities across the value chain to deliver new peptide therapies to people who need them.